Misonidazole
Misonidazole is a chemical compound that has been studied for its potential medical applications, particularly in the field of oncology. It belongs to a class of compounds known as nitroimidazoles, which have shown promise in the treatment of certain types of cancer.
Chemical Structure[edit]
Misonidazole has the chemical formula C₆H₁₂N₄O₃ and a molecular weight of 176.18 g/mol. Its chemical structure consists of a nitroimidazole ring with a methyl group attached to the nitrogen atom.
Medical Uses[edit]
Misonidazole is primarily known for its radiosensitizing properties. When administered to cancer patients prior to radiation therapy, misonidazole can enhance the effectiveness of the treatment by making cancer cells more sensitive to radiation. This can lead to improved outcomes for patients undergoing radiotherapy for various types of cancer.
Mechanism of Action[edit]
The exact mechanism of action of misonidazole as a radiosensitizer is not fully understood. However, it is believed that misonidazole is selectively taken up by hypoxic (low-oxygen) cells within tumors. Once inside these cells, misonidazole undergoes a chemical reaction that generates toxic byproducts when exposed to radiation. This process helps to increase the effectiveness of radiation therapy specifically on the hypoxic regions of the tumor.
Side Effects[edit]
Like any medication, misonidazole can cause side effects in some patients. Common side effects may include nausea, vomiting, dizziness, and headache. In rare cases, more serious side effects such as allergic reactions or neurological symptoms may occur. Patients should be closely monitored during treatment with misonidazole to ensure their safety and well-being.
Research and Clinical Trials[edit]
Research on misonidazole and other nitroimidazoles is ongoing, with the aim of improving cancer treatment outcomes and reducing side effects for patients undergoing radiation therapy. Clinical trials are being conducted to evaluate the efficacy and safety of misonidazole in combination with other cancer treatments.
-
Misonidazole
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian